Effect of immunosuppression on kidney and serum insulin-like growth factor-I (IGF-I), IGF binding proteins, and renal growth following unilateral nephrectomy in rats

Metabolism: Clinical and Experimental

Volumn 47, Issue 7, 1998, Pages 817-823

  Grønbæk, Henning ^a   Skjærbæk, Christian ^a   Ørskov, Hans ^a   Flyvbjerg, Allan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ANIMAL MODEL; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; GROWTH INHIBITION; GROWTH REGULATION; GROWTH RETARDATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN LIKE ACTIVITY; KIDNEY DEVELOPMENT; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031809590     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90119-6     Document Type: Article

References (37)

1. Pennisi AJ, Costin G, Phillips LS, et al: Somatomedin and growth hormone studies in pediatric renal allograft recipients who receive daily prednisone. Am J Dis Child 133:950-954, 1979
2. Rees L, Greene SA, Adlard P, et al: Growth and endocrine function after renal transplantation. Arch Dis Child 63:1326-1332, 1988
3. Schaefer F, Hamill G, Stanhope R, et al: Pulsatile growth hormone secretion in peripubertal patients with chronic renal failure. J Pediatr 119:568-577, 1991
4. Giustina A, Girelli A, Alberti D, et al: Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. Clin Endocrinol (Oxf) 35:491-498, 1991
5. Unterman TG, Phillips LS: Glucocorticoid effects on somatomed-ins and somatomedin inhibitors. J Clin Endocrinol Metab 61:618-626, 1985
6. Gourmelen M, Girard F, Binoux M: Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing syndrome or receiving glucocorticoid therapy. J Clin Endocrinol Metab 54:885-892, 1982
7. Hokken Koelega AC, Stijnen T, de Muinck Keizer Schrama SM, et al: Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation. J Clin Endocrinol Metab 77:932-938, 1993
8. Flyvbjerg A, Thorlacius-Ussing O, Næraa R, et al: Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31:310-314, 1988
9. Flyvbjerg A, Frystyk J, Thorlacius-Ussing O, et al: Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 32:261-265, 1989
10. Feingold R, Winson J, Safirstein R: Cyclosporin inhibits compensatory renal growth. Clin Res 34:559A, 1986 (abstr)
11. Logan JL, Benson B: Retardation of renal growth and ornithine decarboxylase activity by cyclosporin after uninephrectomy in rats. Transplantation 44:559-562, 1987
12. Myers AK, Canale S, Penhos JC, et al: Preservation of renal compensatory growth in uninephrectomized rats by low-dose cyclosporine. Transplantation 49:879-882, 1990
13. D'Ercole AJ, Stiles AD, Underwood LE: Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935-939, 1984
14. Grønbæk H, Frystyk J, Ørskov H, et al: Effect of sodium selenite on growth, insulin-like growth factor binding proteins, and insulin-like growth factor I in rats. J Endocrinol 145:105-112, 1995
15. Grønbæk H, Nielsen B, Østerby R, et al: Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats. Diabetologia 38:135-144, 1995
16. Hossenlopp P, Seurin D, Segovia Quinson B, et al: Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143, 1986
17. Flyvbjerg A, Kessler U, Dorka B, et al: Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 35:589-593, 1992
18. Grønbæk H, Nielsen B, Flyvbjerg A, et al: Effect of graded renal ablation on kidney and serum IGF-I and IGFBPs in rats: Relation to compensatory renal growth. Metabolism 46:29-35, 1997
19. Evan AP, Henry DP, Connors BA, et al: Analysis of insulin-like growth factors (IGF)-I and -II, type II IGF receptor, and IGF-binding protein 2 mRNA and peptide levels in normal and nephrectomized rats. Kidney Int 48:1517-1529, 1995
20. Stiles AD, Sosenko IR, D'Ercole AJ, et al: Relation of kidney tissue somatomedin-C/insulin-like growth factor I to postnephrectomy renal growth in the rat. Endocrinology 117:2397-2401, 1985
21. Catanese VM, Sciavolino PJ, Lango MN: Discordant, organspecific regulation of insulin-like growth factor-I messenger ribonucleic acid in insulin-deficient diabetes in rats. Endocrinology 132:496-503, 1993
22. Miell JP, Buchanan CR, Norman MR, et al: The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment. J Endocrinol 142:547-554, 1994
23. Luo J, Murphy LJ: Regulation of insulin-like growth factor binding protein-3 expression by dexamethasone. Mol Cell Endocrinol 74:213-219, 1990
24. Muhlendahl KE, Weber B, Muller Hess R, et al: Glucocorticosteroids and growth hormone secretion under physiological conditions and in states of steroid excess. Eur J Pediatr 128:113-121, 1978
25. Pralong FP, Miell JP, Corder R, et al: Dexamethasone treatment in man induces changes in 24-hour growth hormone (GH) secretion profile without altering total GH released. J Clin Endocrinol Metab 73:1191-1196, 1991
26. Suikkari AM, Koivisto VA, Rutanen EM, et al: Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266-272, 1988
27. Suikkari A-M, Koivisto VA, Koistinen R, et al: Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor binding protein by insulin. J Clin Endocrinol Metab 68:135-140, 1989
28. Orlowski CC, Ooi GT, Rechler MM: Dexamethasone stimulates transcription of the insulin-like growth factor-binding protein-1 gene in H4-II-E rat hepatoma cells. Mol Endocrinol 4:1592-1599, 1990
29. Luo J, Reid RE, Murphy LJ: Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat. Endocrinology 127:1456-1462, 1990
30. Price WA, Stiles AD, Moats Staats BM, et al: Gene expression of insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology 130:1424-1432, 1992
31. Conover CA, Divertie GD, Lee PD: Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinol (Copenh) 128:140-143, 1993
32. Bach LA, Rechler MM: Insulin-like growth factor binding proteins. Diabetes Rev 3:38-61, 1995
33. Peter MA, Winterhalter KH, Böni-Schnetzler M, et al: Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue. Endocrinology 133:2624-2631, 1993
34. Nogami H, Watanabe T, Kobayashi S: IGF-I and IGF-binding protein gene expression in spontaneous dwarf rats. Am J Physiol 267:E396-E401, 1994
35. Caroni P, Schneider C: Signalling by insulin-like growth factors in paralyzed skeletal muscle: Rapid induction of IGF-1 expression in muscle fibers and prevention of interstitial cell proliferation by IG-FBP-5 and IGFBP-4. J Neurosci 14:3378-3388, 1994
36. Cheung PT, Smith EP, Shimasaki S, et al: Characterization of an insulin-like growth factor binding protein (IGFBP-4) produced by the B104 rat neuronal cell line: Chemical and biological properties and differential synthesis by sublines. Endocrinology 129:1006-1015, 1991
37. Mohan S, Bautista CM, Wergedal J, et al: Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action. Proc Natl Acad Sci USA 86:8338-8342, 1989